Control Print Ltd (CONTROLPR) Q2FY27 Concall Summary - Sep-2026 Qtr
Key Takeaways
- Management is investing over INR 100 crores in its Track and Trace business, with key pharma pilots nearing conclusion.
- The V-Shapes packaging unit has undergone significant restructuring, with costs cut by 25% and 65-70% of staff replaced to tackle execution issues.
- Upcoming government mandates for pharma track and trace in 2027-28 are expected to significantly expand the market, validating the company's long-term investment in this segment.
Performance Overview
- Control Print Ltd reported steady growth in its core Coding and Marking business, which continues to contribute 94-95% of total operating revenue.
- The company is experiencing a positive outlook for its Track and Trace division, with a strong pipeline of orders expected to be delivered in the next two quarters.
- Management is focused on increasing revenue and optimizing costs in overseas subsidiaries, particularly the V-Shapes packaging business, which is in a heavy investment phase.
- Several new technology developments in printers, inks, and cartridges are underway, aimed at creating high-value, IP-protected products.
- A price increase has been implemented, which, combined with expected reductions in input costs, is anticipated to improve profitability in the second half of the year.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.
Tone & Disclosure
Log in to Stocksigma to read the Tone & Disclosure section of this summary.